Patents by Inventor Chi-Chih (Ginny) Kang

Chi-Chih (Ginny) Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220275441
    Abstract: According to various embodiments, a system and method for characterizing protein and nucleic acid content of a plurality of individual particles. The method includes encapsulating individual particles into compartments also containing analyte specific binding complements with oligonucleotide tags comprising a unique molecular identifier sequence, a sequence to identify the analyte specific binding complement, and a homology domain sequence. Allowing the oligonucleotide tags to hybridize on homology domain to form initial tag pairs, amplifying the tag pairs, using an enzyme to cut at the homology domain, allowing tags to re-hybridize, pooling the compartments, and sequencing. Finally, predicting co-encapsulated analytes by computational identification of clusters based on more frequently found oligonucleotide tag pairs.
    Type: Application
    Filed: May 10, 2022
    Publication date: September 1, 2022
    Applicant: Mantra Bio, Inc.
    Inventors: Terry Alden Gaige, Chi-Chih (Ginny) Kang, Catherine Rosemary Planey, Dragan Sebisanovic
  • Patent number: 11414699
    Abstract: According to various embodiments, a system and method for characterizing protein and nucleic acid content of a plurality of individual particles. The method includes encapsulating individual particles into compartments also containing analyte specific binding complements with oligonucleotide tags comprising a unique molecular identifier sequence, a sequence to identify the analyte specific binding complement, and a homology domain sequence. Allowing the oligonucleotide tags to hybridize on homology domain to form initial tag pairs, amplifying the tag pairs, using an enzyme to cut at the homology domain, allowing tags to re-hybridize, pooling the compartments, and sequencing. Finally, predicting co-encapsulated analytes by computational identification of clusters based on more frequently found oligonucleotide tag pairs.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: August 16, 2022
    Assignee: MANTRA BIO, INC.
    Inventors: Terry Alden Gaige, Chi-Chih (Ginny) Kang, Catherine RoseMary Planey, Dragan Sebisanovic
  • Publication number: 20190352708
    Abstract: According to various embodiments, a system and method for characterizing protein and nucleic acid content of a plurality of individual particles. The method includes encapsulating individual particles into compartments also containing analyte specific binding complements with oligonucleotide tags comprising a unique molecular identifier sequence, a sequence to identify the analyte specific binding complement, and a homology domain sequence. Allowing the oligonucleotide tags to hybridize on homology domain to form initial tag pairs, amplifying the tag pairs, using an enzyme to cut at the homology domain, allowing tags to re-hybridize, pooling the compartments, and sequencing. Finally, predicting co-encapsulated analytes by computational identification of clusters based on more frequently found oligonucleotide tag pairs.
    Type: Application
    Filed: May 15, 2019
    Publication date: November 21, 2019
    Applicant: Mantra Bio, Inc.
    Inventors: Terry Alden Gaige, Chi-Chih (Ginny) Kang, Catherine RoseMary Planey, Dragan Sebisanovic
  • Publication number: 20190276820
    Abstract: A system for identifying exosome subpopulations and payloads for potential targeted therapeutics comprises a simultaneous extracellular vesicle membrane and enclosed content detecting composition. The extracellular vesicle membrane and enclosed content detecting composition includes: a bead comprising a selective binding agent; an extracellular vesicle membrane protein-specific DNA tag bound to the selective binding agent and comprising a poly-T end; and an extracellular vesicle-derived RNA comprising a poly-A end bound to the membrane protein-specific DNA tag poly-T end. The composition may comprise cDNA bound to the RNA. The selective binding agent may comprise a barcode and a molecular identifier. The selective binding agent may selectively bind the membrane protein identifier DNA present in a droplet. In some embodiments, the bead may be a magnetic bead. In some embodiments, the bead may be a conductive bead.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 12, 2019
    Applicant: Mantra Bio, Inc.
    Inventors: Terry A. Gaige, Chi-Chih (Ginny) Kang, Catherine RoseMary Planey, Alexander Fen Mok